griffithsin
lectin
potent
antivir
activ
envelop
virus
object
studi
assess
griffithsin
inhibitori
effect
porcin
epidem
diarrhea
viru
pedv
result
show
griffithsin
reduc
pedv
infect
vero
cell
approxim
moreov
use
timeofaddit
assay
rtqpcr
found
delay
addit
griffithsin
weaker
inhibitori
effect
pedv
earlier
treatment
mechan
griffithsin
action
pedv
involv
prevent
viral
attach
host
cell
disrupt
celltocel
transmiss
dual
mode
action
distinguish
griffithsin
antivir
drug
conclus
griffithsin
identifi
potent
pedv
inhibitor
may
repres
candid
drug
prevent
pedv
infect
griffithsin
highmannosespecif
lectin
griffithsia
spp
marin
red
alga
broadspectrum
antivir
activ
griffithsin
potent
antihuman
immunodefici
viru
hiv
agent
describ
date
effect
concentr
ec
low
picomolar
rang
moreov
griffithsin
exert
antivir
activ
multipl
envelop
virus
includ
sever
acut
respiratori
syndrom
corona
viru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
hepat
c
viru
hcv
herp
simplex
viru
type
japanes
enceph
viru
jev
least
one
nonenvelop
viru
human
papilloma
viru
griffithsin
show
favor
safeti
profil
tcell
activ
activ
littl
impact
cytokin
chemokin
releas
immun
cell
well
excel
stabil
broad
rang
ph
temperatur
proteas
exposur
characterist
make
griffithsin
attract
candid
develop
antivir
therapeut
activ
porcin
epidem
diarrhea
viru
pedv
remain
unexplor
pedv
infect
pig
popul
asia
europ
north
america
caus
huge
econom
loss
pedv
highli
contagi
enter
infect
character
acut
wateri
diarrhea
vomit
dehydr
pig
age
infect
pedv
infect
especi
seriou
suckl
piglet
morbid
mortal
often
reach
enteropathogen
coronaviru
pedv
singlestrand
positivesens
rna
genom
approxim
kb
size
encod
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
protein
pedv
protein
major
type
glycoprotein
locat
viral
surfac
contain
put
nglycosyl
site
play
import
role
viral
entri
make
attract
target
chemotherapeut
intervent
studi
show
griffithsin
inhibit
pedv
infect
vero
cell
also
elucid
detail
mechan
griffithsin
inhibitori
action
pedv
infect
vero
cell
african
green
monkeyderiv
kidney
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
usa
supplement
vv
fetal
bovin
serum
atmospher
co
chines
pedv
isol
njpedv
isol
identifi
store
laboratori
nation
research
center
engin
technolog
veterinari
biolog
jiangsu
academi
agricultur
scienc
njpedv
strain
propag
vero
cell
viral
stock
titer
determin
tcid
protein
product
perform
describ
pet
system
manual
novagen
usa
e
coli
cell
griffithsin
gene
genbank
codonoptim
e
coli
express
synthes
clone
vector
genscript
nanj
china
recombin
griffithsin
gene
introduc
vector
obtain
recombin
express
plasmid
plasmid
transform
compet
e
coli
cell
obtain
recombin
e
coli
strain
select
ampicillin
chloramphenicol
meanwhil
neg
control
recombin
e
coli
strain
grown
overnight
lb
broth
overnight
cultur
dilut
ml
fresh
lb
broth
induc
mm
isopropylbetadthiogalactopyranosid
iptg
incub
h
protein
griffithsin
extract
purifi
use
ml
ni
sepharos
histrap
affin
column
ge
healthcar
sweden
elut
mm
imidazol
pb
protein
dialyz
remov
imidazol
follow
endotoxin
remov
use
endotoxin
remov
kit
genscript
china
filter
steril
quantifi
use
bca
protein
assay
reagent
kit
pierc
usa
final
sdspage
western
blot
use
analyz
protein
product
flatbottom
microtit
plate
nunc
maxiscorp
md
usa
coat
either
pedv
ml
purifi
ultracentrifug
wv
bovin
serum
albumin
bsa
mm
carbon
buffer
ph
overnight
incub
well
block
phosphatebuff
salin
pb
contain
vv
pbst
bsa
h
titrat
concentr
griffithsin
volum
ad
well
competit
elisa
variou
dilut
griffithsin
preincub
mannos
glucos
antihi
tag
antibodi
boster
wuhan
china
horseradish
peroxidaseconjug
hrp
secondari
antibodi
boster
wuhan
china
use
detect
griffithsin
bind
hrp
detect
tmb
substrat
ad
reaction
stop
h
absorb
measur
use
micropl
spectrophotomet
biotec
wavelength
nm
cytotox
evalu
use
mtt
assay
vero
cell
seed
well
plate
densiti
cell
per
well
next
day
variou
concentr
griffithsin
ad
cell
incub
h
mtt
ad
well
incub
addit
h
supernat
remov
dimethyl
sulfoxid
ad
dissolv
color
formazan
crystal
absorb
measur
wavelength
nm
vero
cell
seed
well
plate
cultur
overnight
atmospher
co
variou
concentr
griffithsin
incub
pedv
min
room
temperatur
subsequ
use
infect
cell
multipl
infect
moi
h
cell
wash
pb
fresh
medium
contain
fetal
bovin
serum
ad
control
group
griffithsin
preincub
mm
mannos
incub
pedv
h
cell
fix
precool
methanol
min
airdri
block
pb
contain
bsa
h
cell
incub
mous
antipedv
monoclon
antibodi
dilut
gener
gift
haom
zhang
fitcconjug
goat
antimous
igg
dilut
boster
wuhan
china
h
wash
cell
stain
dapi
min
room
temperatur
wash
observ
use
five
cell
imag
multimod
reader
biotek
timeofaddit
assay
griffithsin
conduct
previous
describ
modif
subconflu
vero
cell
monolay
infect
pedv
moi
h
wash
pb
ml
griffithsin
ad
cell
either
h
h
h
pedv
infect
infect
cell
treat
griffithsin
use
control
h
cell
collect
subject
rtqpcr
total
rna
extract
use
minibest
univers
rna
extract
kit
takara
osaka
japan
rna
revers
transcrib
firststrand
cdna
use
revers
transcriptas
takara
rtqpcr
perform
lightcycl
ii
system
roch
basel
switzerland
use
evagreen
qpcr
mastermixno
dye
kit
abm
canada
accord
manufactur
recommend
forward
primer
fp
revers
primer
rp
pedv
gene
gapdh
gene
follow
ctg
cgt
tct
tgt
atg
ccg
aat
gct
att
gac
gapdhfp
tcc
gtg
tcc
cta
ctg
gapdhrp
gcc
tgc
ttc
acc
acc
data
analyz
use
method
mean
rna
level
control
cell
treat
griffithsin
assign
valu
assay
perform
triplic
attach
assay
vero
cell
well
plate
precool
min
simultan
infect
pedv
moi
treat
griffithsin
h
penetr
assay
pedv
virion
allow
attach
cell
h
wash
pb
cell
simultan
warm
treat
griffithsin
addit
h
final
cell
wash
pb
collect
rtqpcr
analysi
describ
cell
treat
griffithsin
use
control
celltocel
spread
assess
previous
describ
modif
vero
cell
incub
pedv
moi
h
wash
pb
remov
unbound
virion
cell
cultur
fresh
medium
contain
griffithsin
monoclon
neutral
antibodi
nab
gener
gift
haom
zhang
cell
cultur
medium
contain
nab
griffithsin
serv
control
h
incub
cell
fix
precool
methanol
indirect
immunofluoresc
assay
data
present
mean
standard
deviat
three
independ
experi
differ
group
mean
analyz
use
student
test
graphpad
prism
softwar
statist
signific
assum
p
design
recombin
gene
encod
griffithsin
tag
cterminu
recombin
griffithsin
analyz
sdspage
western
blot
use
antihi
monoclon
antibodi
shown
fig
observ
griffithsin
purifi
nickel
affin
chromatographi
b
western
blot
analysi
use
antihi
tag
antibodi
lane
griffithsin
purifi
nickel
affin
chromatographi
band
expect
molecular
weight
kda
major
recombin
griffithsin
protein
present
e
coli
cytoplasm
solubl
form
purifi
protein
dialyz
follow
endotoxin
remov
filter
steril
prior
use
investig
whether
griffithsin
could
bind
pedv
perform
elisa
immobil
pedv
virion
previous
describ
elisa
experi
demonstr
griffithsin
could
bind
pedv
dosedepend
manner
shown
fig
moreov
griffithsin
bind
pedv
effici
inhibit
preincub
mannos
glucos
fig
indic
pedv
glycan
may
involv
bind
griffithsin
pedv
data
impli
potenti
antivir
activ
griffithsin
pedv
antivir
assay
perform
determin
whether
bind
griffithsin
pedv
affect
infect
effect
griffithsin
concentr
pedv
infect
vero
cell
shown
fig
preincub
pedv
griffithsin
result
signific
reduct
infect
compar
untreat
pedv
virion
infect
vero
cell
pedv
moi
infect
rate
decreas
absenc
griffithsin
treatment
presenc
griffithsin
respect
griffithsin
exhibit
much
stronger
inhibitori
effect
vero
cell
infect
moi
infect
rate
decreas
absenc
griffithsin
treatment
quantit
pedvinfect
cell
treatment
griffithsin
result
express
percentinfect
cell
calcul
number
infect
cell
fitc
stain
total
number
cell
dapi
nuclei
stain
valu
repres
mean
three
independ
experi
standard
deviat
p
p
p
compar
control
group
b
griffithsin
concentr
preincub
mannos
presenc
griffithsin
respect
shown
fig
griffithsin
inhibit
pedv
infect
dosedepend
manner
inhibitori
effect
lost
griffithsin
preincub
mannos
cytotox
griffithsin
vero
cell
studi
result
show
prolif
activ
vero
cell
unaffect
griffithsin
concentr
rang
result
suggest
griffithsin
possess
antivir
activ
pedv
cytotox
activ
mammalian
cell
timeofaddit
assay
conduct
evalu
whether
griffithsin
inhibitori
efficaci
vari
differ
period
pedv
infect
viral
rna
level
vero
cell
quantit
h
last
griffithsin
addit
surprisingli
shown
fig
addit
griffithsin
result
signific
reduct
viral
rna
level
time
point
compar
viru
alon
control
p
moreov
found
delay
addit
griffithsin
result
weaker
inhibitori
effect
pedv
griffithsin
complet
suppress
pedv
infect
ad
viru
inocul
h
howev
viral
rna
load
exhibit
similar
reduct
griffithsin
ad
viru
inocul
h
contrast
griffithsin
show
modest
inhibitori
effect
ad
h
postviru
inocul
viral
rna
load
higher
compar
addit
h
postinocul
data
indic
griffithsin
stronger
inhibitori
effect
initi
stage
pedv
infect
understand
antivir
mechan
griffithsin
pedv
effect
viral
attach
penetr
evalu
result
clearli
show
griffithsin
could
block
viral
attach
modest
effect
viral
penetr
fig
attach
assay
show
viral
rna
load
reduc
approxim
tenfold
compar
control
cell
p
howev
griffithsin
littl
effect
infect
ad
viral
penetr
p
viral
rna
load
unaffect
griffithsin
addit
compar
control
group
preincub
mannos
although
uncertain
whether
pedv
spread
direct
celltocel
contact
without
pass
cellfre
stage
celltocel
spread
observ
studi
mani
envelop
virus
thu
specul
celltocel
spread
pedv
could
inhibit
griffithsin
monoclon
nab
ad
complet
neutral
releas
virion
pedv
celltocel
transmiss
clearli
effici
suppress
griffithsin
shown
fig
b
caus
signific
reduct
number
pedvinfect
cell
dosedepend
manner
infect
rate
reduc
cell
treat
nab
alon
cell
treat
griffithsin
respect
interestingli
infect
fig
effect
griffithsin
pedv
entri
stage
control
group
cell
infect
pedv
without
griffithsin
treatment
stage
data
present
mean
standard
deviat
three
independ
experi
p
p
p
compar
control
group
data
present
mean
standard
deviat
three
independ
experi
p
p
p
compar
control
group
rate
reduc
show
stronger
antivir
activ
compar
group
treat
nab
alon
importantli
griffithsin
also
promot
format
discret
foci
infect
studi
provid
initi
evid
griffithsin
antivir
activ
pedv
moreov
antivir
mechan
action
mean
griffithsin
may
repres
attract
drug
chemotherapeut
intervent
griffithsin
abl
prevent
infect
cellfre
viru
also
abl
prevent
viral
spread
infect
uninfect
cell
properti
may
make
griffithsin
superior
antivir
drug
thu
griffithsin
may
promis
tool
combat
pedv
griffithsin
bound
pedv
glycandepend
manner
indic
griffithsin
antivir
activ
may
depend
interact
viral
glycan
demonstr
griffithsin
reduc
infect
vero
cell
infect
pedv
moi
furthermor
griffithsin
reduc
pedv
infect
vero
cell
contrast
concentr
reduc
infect
cell
infect
prrsv
moi
five
previou
studi
griffithsin
also
display
antivir
activ
envelop
virus
variou
degre
much
potent
activ
hiv
compar
result
shown
pedv
reason
underli
differ
complet
understood
follow
potenti
caus
may
provid
part
explan
firstli
structur
composit
glycan
well
glycosyl
level
envelop
glycoprotein
may
affect
bind
affin
griffithsin
major
determin
antivir
activ
secondli
densiti
envelop
spike
may
import
factor
determin
griffithsin
activ
virion
averag
spike
per
virion
particl
compar
influenza
type
viru
four
spike
suffici
hiv
infect
thu
block
infect
one
hiv
virion
griffithsin
must
neutral
four
spike
probabl
explain
griffithsin
display
stronger
inhibitori
effect
hiv
infect
compar
envelop
virus
data
clearli
show
griffithsin
could
block
viral
adsorpt
modest
effect
viral
penetr
interestingli
found
griffithsin
could
inhibit
pedv
infect
block
celltocel
transmiss
previou
studi
show
griffithsin
display
antivir
activ
prrsv
block
virion
attach
viral
penetr
moreov
studi
shown
inhibit
merscov
griffithsin
might
result
failur
viru
attach
target
cell
contrast
nixon
report
griffithsin
inhibit
infect
disrupt
celltocel
spread
act
entri
stage
reason
fig
effect
griffithsin
treatment
pedv
celltocel
spread
use
immunofluoresc
microscopi
indirect
immunofluoresc
assay
perform
assess
effect
griffithsin
celltocel
spread
pedv
b
quantit
pedvinfect
cell
treatment
griffithsin
valu
repres
mean
three
independ
experi
standard
deviat
nab
ad
nab
ad
arab
numer
concentr
griffithsin
differ
mechan
action
may
relat
viru
receptor
detail
mechan
remain
explor
futur
studi
understand
mechan
action
griffithsin
pedv
detail
assess
griffithsin
inhibitori
efficaci
ad
differ
stage
pedv
infect
griffithsin
treatment
caus
signific
reduct
viral
rna
load
time
addit
addit
griffithsin
viral
inocul
h
caus
fold
reduct
viral
load
compar
uninfect
cell
contrast
addit
griffithsin
h
postinocul
caus
eightfold
reduct
viral
load
respect
find
indic
earlier
treatment
griffithsin
result
stronger
inhibitori
effect
pedv
infect
antivir
activ
griffithsin
vivo
wide
studi
vivo
efficaci
griffithsin
sarscov
jev
hcv
evalu
murin
model
result
show
griffithsin
treatment
protect
effect
shown
anim
weight
morbid
mortal
target
tissu
viral
titer
interestingli
barri
colleagu
indic
sarscovinfect
mice
treat
griffithsin
lose
weight
surviv
howev
mice
treat
griffithsin
experienc
decreas
weight
surviv
rate
moreov
bioavail
studi
anim
demonstr
griffithsin
could
accumul
high
level
serum
subcutan
deliveri
serum
griffithsintr
anim
retain
antivir
activ
find
suggest
griffithsin
may
promis
candid
system
antivir
therapeut
studi
live
anim
necessari
confirm
valu
inhibit
pedv
infect
vivo
potenti
lead
new
antivir
intervent
conclus
found
griffithsin
potent
antipedv
activ
via
prevent
viral
attach
celltocel
spread
moreov
studi
reveal
griffithsin
exhibit
stronger
effect
pedv
infect
ad
earli
stage
infect
studi
live
anim
necessari
develop
novel
antivir
strategi
pedv
therapi
